CRSP icon

CRISPR Therapeutics
CRSP

Overview Fund Activity

469 hedge funds and large institutions have $3.5B invested in CRISPR Therapeutics in 2023 Q4 according to their latest regulatory filings, with 120 funds opening new positions, 133 increasing their positions, 124 reducing their positions, and 45 closing their positions.

Holders
469
Holders Change
+66
Holders Change %
+16.38%
% of All Funds
6.88%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
120
Increased
133
Reduced
124
Closed
45
Calls
$304M
Puts
$301M
Net Calls
+$3.03M
Net Calls Change
+$14M

Top Buyers

1
AIM
1
ARK Investment Management
Florida
$534M
2
Voloridge Investment Management
2
Voloridge Investment Management
Florida
$45.5M
3
Morgan Stanley
3
Morgan Stanley
New York
$51.7M
4
Jane Street
4
Jane Street
New York
$29.7M
5
Citadel Advisors
5
Citadel Advisors
Florida
$17.1M

Top Sellers

1
AC
1
Armistice Capital
New York
$10.5M
2
Allspring Global Investments
2
Allspring Global Investments
North Carolina
$2.32M
3
Franklin Resources
3
Franklin Resources
California
$373K
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$115M
5
Westfield Capital Management
5
Westfield Capital Management
Massachusetts
$0
Name Market Value Shares Shares
Change 		Shares
Change %
AIM
1
ARK Investment Management
Florida
$534M 8,536,104 +1,372,986 +19%
Capital International Investors
2
Capital International Investors
California
$384M 6,134,450 +48,938 +0.8%
T. Rowe Price Investment Management
3
T. Rowe Price Investment Management
Maryland
$226M 3,611,186 -40,647 -1%
Sumitomo Mitsui Trust Group
4
Sumitomo Mitsui Trust Group
Japan
$211M 3,369,762 -95,708 -3%
NAMA
5
Nikko Asset Management Americas
New York
$211M 3,369,762 -95,708 -3%
BlackRock
6
BlackRock
New York
$158M 2,516,486 -196,724 -7%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$115M 1,839,871 -217,543 -11%
State Street
8
State Street
Massachusetts
$110M 1,753,497 -131,476 -7%
Vanguard Group
9
Vanguard Group
Pennsylvania
$99.6M 1,590,651 +51,926 +3%
NMC
10
NEA Management Company
Maryland
$99.4M 1,587,854 – –
Loomis, Sayles & Company
11
Loomis, Sayles & Company
Massachusetts
$66.8M 1,067,351 -29,003 -3%
BG
12
Bellevue Group
Switzerland
$56.4M 900,400 +2,000 +0.2%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$55.3M 883,729 +33,791 +4%
CS
14
Credit Suisse
Switzerland
$54.8M 876,145 +3,214 +0.4%
T. Rowe Price Associates
15
T. Rowe Price Associates
Maryland
$54.1M 864,346 -5,291 -0.6%
Morgan Stanley
16
Morgan Stanley
New York
$51.7M 826,154 +474,719 +135%
Dimensional Fund Advisors
17
Dimensional Fund Advisors
Texas
$48.8M 779,454 -100,347 -11%
Voloridge Investment Management
18
Voloridge Investment Management
Florida
$45.5M 726,887 +726,887 New
Bank of America
19
Bank of America
North Carolina
$43.3M 691,170 +11,471 +2%
Charles Schwab
20
Charles Schwab
California
$40.9M 653,023 +15,085 +2%
Norges Bank
21
Norges Bank
Norway
$38.7M 617,586 +31,286 +5%
Federated Hermes
22
Federated Hermes
Pennsylvania
$31.8M 508,100 – –
VVM
23
Versant Venture Management
California
$31.2M 498,558 – –
Jane Street
24
Jane Street
New York
$29.7M 475,008 +349,887 +280%
JPMorgan Chase & Co
25
JPMorgan Chase & Co
New York
$29M 463,270 -57,159 -11%
1
2 3 4 5